Market Size of Telemonitoring Systems Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 13.41 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Telemonitoring Systems Market Analysis
The telemonitoring systems market was evaluated at USD 2,450.2 million in 2020, and it is expected to reach a value of USD 5,305.8 million by 2026, registering a CAGR of 13.41% over the forecast period, 2021 - 2026. As telemonitoring refers to the process that comprises transmission of symptom scores, physiological patient data, such as the heart rate, oxygen saturation, blood pressure, and others, the usage of IoT is significantly driving the new trend in the studied market. Devices, like IoT-enabled medical wearable temperature sensors to transmit data to a central monitoring system remotely, are already being implemented in regions, such as North America. Medical staff is alerted based on trends and thresholds, identifying the patient and room, and can respond accordingly. Further, in countries such as in Europe, it is predicted that the use of IoT in the region may increase almost three-fold between 2017 and 2025, reaching 4.9 billion connected devices, increasing the integration of telemonitoring systems significantly.
- Increasing chronic diseases and the growing aging population is driving the market. The global population is aging at a rapid pace, owing to various government initiatives to enhance the longevity revolution. Most developed nations are increasingly observing growth in the number of the aging population. According to the UN data, in 2019, there were 703 million people aged 65 or older, and the number is projected to reach 1.5 billion by 2050. The world is observing a significant increase in the number of chronic diseases, especially in terms of hypertension, diabetes, and respiratory problems. According to IDF, in 2019, 463 million adults were living with diabetes, and by 2045, this is expected to increase to 700 million. Furthermore, 1 in 5 of the people that are above 65 years are suffering from diabetes.
- Rising healthcare expenditure is driving the market. The global Medicaid expenditure increased significantly over the years. According to CMS, the global Medicaid expenditure in 2019 was valued at USD 639.4 billion, which was USD 616 billion during the previous year. Further, a significant share of global healthcare spending is directed toward the purchase of equipment. For instance, in 2019, the UK's consumer spending on medical products, appliances, and equipment was valued at GBP 16,685 million, according to the Office for National Statistics (UK). Such developments are expected to influence the demand for telemonitoring.
- Further, the healthcare expenditure to treat diabetes in the United States during 2019 was valued at USD 294.6 billion, and in China, it was valued at USD 109 billion, according to the International Diabetes Federation. Such growth is expected to further augment the demand for monitoring devices by patients undergoing the treatment.
- Furthermore, the impact of COVID-19 has been evident with the sudden spurt in demand as the investment in healthcare infrastructure has experienced a sudden increase to improve health services. The demand for telemonitoring system is expected to spearhead over the coming years due to the outbreak of COVID-19. As the government across the world has announced to reduce non-emergency visits to the hospitals and postpone surgeries, in-case they are not on an emergency, so it influences both patients and healthcare professionals to adopt remote monitoring systems.
- Telemonitoring solution vendors are increasingly working with the government and healthcare industry to encourage the use of such systems. For example, Phillips is enabling hospitals in the Netherlands to remotely screen and monitor patients with COVID-19.
Telemonitoring Systems Industry Segmentation
Telemonitoring has various modes of operations, such as real-time mode, wherein the data of a patient is available on the server, and store-and-forward mode involves accessing the data at a later time. The market product comprises of COPD Telemonitoring System, Glucose Level Telemonitoring System, Cardiac Telemonitoring System, and others.
By Product Type | |
COPD Telemonitoring System | |
Glucose Level Telemonitoring System | |
Cardiac Telemonitoring System | |
Blood Pressure Telemonitoring System | |
Other Product Types |
Geography | |
North America | |
Europe | |
Asia Pacific | |
Latin America | |
Middle-East and Africa |
Telemonitoring Systems Market Size Summary
The telemonitoring systems market is experiencing significant growth, driven by the increasing prevalence of chronic diseases and the aging global population. The integration of Internet of Things (IoT) technology into telemonitoring devices is a key trend, facilitating remote monitoring of vital signs such as heart rate, oxygen saturation, and blood pressure. This technological advancement is particularly evident in regions like North America and Europe, where IoT-enabled medical wearables are being widely adopted. The market is further bolstered by rising healthcare expenditures and the need for efficient healthcare solutions, especially in the wake of the COVID-19 pandemic, which has accelerated the adoption of remote monitoring systems to reduce non-emergency hospital visits.
In addition to technological advancements, the market is characterized by a competitive landscape with numerous players introducing innovative telemonitoring solutions. Companies like Abbott Laboratories and GE Healthcare are at the forefront, developing smart medical devices and cloud-based monitoring software. The market's growth is also supported by strategic partnerships and product innovations aimed at enhancing the functionality and accessibility of telemonitoring systems. As countries in Asia, such as India, Japan, and Singapore, emerge as health tech hubs, the demand for telemonitoring solutions is expected to rise, driven by the increasing adoption of technology in healthcare and the need to manage chronic conditions effectively.
Telemonitoring Systems Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Industry Attractiveness - Porter's Five Force Analysis
-
1.2.1 Bargaining Power of Suppliers
-
1.2.2 Bargaining Power of Consumers
-
1.2.3 Threat of New Entrants
-
1.2.4 Intensity of Competitive Rivalry
-
1.2.5 Threat of Substitute Products
-
-
1.3 Assessment of Impact of Covid-19 on the Industry
-
-
2. MARKET SEGMENTATION
-
2.1 By Product Type
-
2.1.1 COPD Telemonitoring System
-
2.1.2 Glucose Level Telemonitoring System
-
2.1.3 Cardiac Telemonitoring System
-
2.1.4 Blood Pressure Telemonitoring System
-
2.1.5 Other Product Types
-
-
2.2 Geography
-
2.2.1 North America
-
2.2.2 Europe
-
2.2.3 Asia Pacific
-
2.2.4 Latin America
-
2.2.5 Middle-East and Africa
-
-
Telemonitoring Systems Market Size FAQs
What is the current Telemonitoring Systems Market size?
The Telemonitoring Systems Market is projected to register a CAGR of 13.41% during the forecast period (2024-2029)
Who are the key players in Telemonitoring Systems Market?
Abbott Laboratories, Care Innovations LLC, GE Healthcare Systems (General Electric System), Koninklijke Philips NV and Aerotel Medical Systems Ltd are the major companies operating in the Telemonitoring Systems Market.